These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22581115)

  • 41. Treatment with a fusion protein of the extracellular domains of NKG2D to IL-15 retards colon cancer growth in mice.
    Xia Y; Chen B; Shao X; Xiao W; Qian L; Ding Y; Ji M; Gong W
    J Immunother; 2014 Jun; 37(5):257-66. PubMed ID: 24810637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma.
    Marchi LH; Paschoalin T; Travassos LR; Rodrigues EG
    Cancer Gene Ther; 2011 Feb; 18(2):110-22. PubMed ID: 20885448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stable transduction of the interleukin-2 gene into human natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo.
    Nagashima S; Mailliard R; Kashii Y; Reichert TE; Herberman RB; Robbins P; Whiteside TL
    Blood; 1998 May; 91(10):3850-61. PubMed ID: 9573023
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion protein.
    Ochoa MC; Fioravanti J; Rodriguez I; Hervas-Stubbs S; Azpilikueta A; Mazzolini G; Gúrpide A; Prieto J; Pardo J; Berraondo P; Melero I
    Cancer Res; 2013 Jan; 73(1):139-49. PubMed ID: 23149919
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Augmentation of IL-2 activated natural killer cell adoptive immunotherapy with cyclophosphamide.
    Goldfarb RH; Ohashi M; Brunson KW; Kirii Y; Kotera Y; Basse PH; Kitson RP
    Anticancer Res; 1998; 18(3A):1441-6. PubMed ID: 9673353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of natural killer cell-dependent antitumor immunity by the Autographa californica multiple nuclear polyhedrosis virus.
    Kitajima M; Abe T; Miyano-Kurosaki N; Taniguchi M; Nakayama T; Takaku H
    Mol Ther; 2008 Feb; 16(2):261-8. PubMed ID: 18059370
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The anti-lung cancer activity of SEP is mediated by the activation and cytotoxicity of NK cells via TLR2/4 in vivo.
    Ke M; Wang H; Zhang M; Tian Y; Wang Y; Li B; Yu J; Dou J; Xi T; Zhou C
    Biochem Pharmacol; 2014 May; 89(1):119-30. PubMed ID: 24630931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo.
    Sun R; Wei H; Zhang J; Li A; Zhang W; Tian Z
    Neuroimmunomodulation; 2002-2003; 10(3):169-76. PubMed ID: 12481157
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor-localization by adoptively transferred, interleukin-2-activated NK cells leads to destruction of well-established lung metastases.
    Yang Q; Hokland ME; Bryant JL; Zhang Y; Nannmark U; Watkins SC; Goldfarb RH; Herberman RB; Basse PH
    Int J Cancer; 2003 Jul; 105(4):512-9. PubMed ID: 12712443
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NK cells are the crucial antitumor mediators when STAT3-mediated immunosuppression is blocked in hepatocellular carcinoma.
    Sui Q; Zhang J; Sun X; Zhang C; Han Q; Tian Z
    J Immunol; 2014 Aug; 193(4):2016-23. PubMed ID: 25015826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy.
    Lopes JE; Fisher JL; Flick HL; Wang C; Sun L; Ernstoff MS; Alvarez JC; Losey HC
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32317293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adoptive transfer of natural killer cells promotes the anti-tumor efficacy of T cells.
    Goding SR; Yu S; Bailey LM; Lotze MT; Basse PH
    Clin Immunol; 2017 Apr; 177():76-86. PubMed ID: 27377534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mouse interleukin-12/FasTI: A novel bi-functional fusion protein for cancer immuno/gene therapy.
    Yang X; Tietje AH; Yu X; Wei Y
    Int J Oncol; 2016 Jun; 48(6):2381-6. PubMed ID: 27081758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Natural killer cell depletion confounds the antitumor mechanism of endogenous IL-12 overexpression.
    Miller G; Bleier JI; Antonescu C; Pillarisetty VG; Shah AB; Lahrs S; DeMatteo RP
    Int J Cancer; 2004 Jun; 110(3):395-402. PubMed ID: 15095305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptor.
    Sahm C; Schönfeld K; Wels WS
    Cancer Immunol Immunother; 2012 Sep; 61(9):1451-61. PubMed ID: 22310931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells.
    Leong JW; Chase JM; Romee R; Schneider SE; Sullivan RP; Cooper MA; Fehniger TA
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):463-73. PubMed ID: 24434782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Eukaryotic expression of recombinant porcine single-chain IL-12 and its biologic activity].
    Wang XM; Yuan YY; Fang Q; Xia H; Sun X; Li BQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jul; 28(7):691-5. PubMed ID: 22768856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15.
    Imamura M; Shook D; Kamiya T; Shimasaki N; Chai SM; Coustan-Smith E; Imai C; Campana D
    Blood; 2014 Aug; 124(7):1081-8. PubMed ID: 25006133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lung natural killer cells play a major counter-regulatory role in pulmonary vascular hyperpermeability after myocardial infarction.
    Yan X; Hegab AE; Endo J; Anzai A; Matsuhashi T; Katsumata Y; Ito K; Yamamoto T; Betsuyaku T; Shinmura K; Shen W; Vivier E; Fukuda K; Sano M
    Circ Res; 2014 Feb; 114(4):637-49. PubMed ID: 24366170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced antitumor response mediated by the codelivery of paclitaxel and adenoviral vector expressing IL-12.
    Cao L; Zeng Q; Xu C; Shi S; Zhang Z; Sun X
    Mol Pharm; 2013 May; 10(5):1804-14. PubMed ID: 23534449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.